Foley Advises Kaia Health on $285M Sale to Sword Health

Foley & Lardner LLP advised Kaia Health, a digital therapeutics company focused on musculoskeletal (MSK) and pulmonary care, on its $285 million sale to Sword Health.

Kaia Health has enabled broad access to digital MSK and COPD care for millions of members through multiple well-established partnerships. Following the acquisition, these populations will be further supported by Sword Health’s AI Care platform, ensuring uninterrupted care while benefiting from Sword’s industry-leading outcomes, engagement, and cost efficiency.

The Foley team served as legal counsel for health care regulatory and executive compensation issues and was led by partners Thomas (T.J.) Ferrante, vice chair of the firm’s nationally recognized Health Care Practice Group, and Casey Knapp, vice chair of the firm’s Business Law Department, and included support from Senior Counsel, Kelsey O’Gorman.

The Telemedicine & Digital Health Industry Team helps venture-backed and high-growth companies embrace emerging issues in virtual care, enabling them to provide innovative care for patients in new markets around the block and around the world. Foley is committed to helping entrepreneurs fulfill their goals of harnessing new technology to reach patients anywhere, delivering care without borders or geographic limitations. The firm helps create fully-fledged telemedicine offerings, providing end-to-end legal services by coupling precise strategic guidance with rapid turnarounds to maintain that sense of urgency necessary to launch new initiatives and remain competitive in the marketplace. Learn more at www.foley.com/telemedicine.